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1875-9572/Copyright ª 2014, TaiwanBackground: Racial variability in certain prenatal risk factors, such as prenatal vitamin supple-
mentation and termination of pregnancy for fetal anomaly, has altered the racial prevalence
of birth defects. Analysis of a single large representative population is required to analyze cur-
rent racial differences in the prevalence of birth defects in the United States.
Methods: This is a population-based cross-sectional study to analyze racial differences in the
prevalence of birth defects. We reviewed all live births in the 2008 Nationwide Inpatient Sam-
ple (NIS) database and determined birth prevalence of 55 selected birth defects in Caucasians.
We then calculated the relative risk of these birth defects in AfricaneAmericans, Hispanics,
and Asians relative to Caucasians.
Result: Overall birth defect prevalence was 29.2 per 1000 in a cohort of 1,048,252 live births,
of which 51% were Caucasians. Compared with Caucasians, the risk of overall birth defects was
lower in AfricaneAmericans (relative risk Z 0.9, confidence interval 0.8e0.9) and Hispanics
(relative riskZ 0.9, confidence interval 0.8e0.9). The risk of overall birth defects was similar
in Caucasians and Asians. Relative to the Caucasians, AfricaneAmericans had a lower risk of
cardiac, genitourinary, and craniofacial malformations but a higher risk of musculoskeletal
malformations. Hispanics had a lower risk of genitourinary and gastrointestinal malformation.
Asians had a higher risk of craniofacial and musculoskeletal malformations.
Conclusion: This is a comprehensive description of racial differences in the risk of birth defects
in the United States. Observed racial differences in the risk of birth defects may be related to
genetic susceptibilities, to cultural or social differences that could modify exposures, or to the
many potential combinations between susceptibilities and exposures.
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.ediatric Cardiology, Mount Sinai Medical Center, One Gustave Levy Place, New York, NY 10029, USA.
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184 A.C. Egbe1. Introduction
Birth defects are the leading cause of infant mortality and
morbidity. The proportion of infant mortality due to birth
defects has increased significantly from 15.1% in the 1970s
to 22.1% in the late 1990s, making them the leading cause
of infant mortality.1,2 Birth defects account forw12% of all
pediatric hospitalizations and a significant portion of health
care costs in the United States.3 The burden of birth de-
fects goes beyond childhood because it is responsible for
w2.3% of cases of premature death and disability, as
measured by disability-adjusted life years, among the
United States population.4 Based on the above evidence, it
is apparent that birth defects are a major public health
problem because of their significant contribution to mor-
tality and morbidity.
There is variability in reproductive outcomes among
different racial groups. For instance, the risk of preterm
delivery, low birth weight, and infant mortality is highest
among AfricaneAmericans and lowest among
Caucasians.5e7 Prior studies have described racial differ-
ences in the prevalence of selected birth defects8e10 but
there is paucity of data showing comprehensive analysis of
racial differences in the prevalence of all major birth
defect diagnosis. Modification of certain prenatal risk fac-
tors such as prenatal vitamin supplementation and termi-
nation of pregnancy for fetal anomaly (TOPFA) has been
shown to alter birth defect prevalence in the general
population.11e14 However, there is significant variability in
the rate of TOPFA and general prenatal care based on race,
socioeconomic status, and geographic location.15e17 We
hypothesized that racial variability in prenatal risk factors
has altered the racial prevalence of birth defects in the
United States. Our study objective was to provide
population-based estimates of racial differences on birth
defect prevalence among newborns in the United States.
2. Materials and methods
2.1. Data collection
All data were derived from the Nationwide Inpatient Sam-
ple (NIS), Healthcare Cost and Utilization Project (HCUP),
and Agency for Healthcare Research and Quality.18 The
2008 NIS is an all-payer administrative database reporting
clinical and resource use information representative of
hospitalizations in 42 states. We chose the NIS database
instead of other databases such the Kids’ Inpatient Data-
base (KID) because NIS is the largest available inpatient
care database in the United States, containing w8 million
hospital stays each year from w1000 hospitals sampled to
w20% stratified sample of United States community hospi-
tals. The NIS large sample size makes it ideal for analysis of
rare conditions such as specific congenital malformations.
In addition, most newborn deliveries occur in adult hospi-
tals, and NIS captures these hospitalizations to provide an
invaluable resource in achieving our primary objective, to
estimate the birth prevalence of congenital malformations.
Approval for this study was obtained from both HCUP and
the Institutional Review Board (Mount Sinai Medical Center,
NY).We reviewed the NIS database from January 2008 to
December 2008 and identified 1,204,887 live births (birth
hospitalizations) and we included 1,048,252 live births (87
%) with available race data in our final cohort. All cases of
birth defects during birth hospitalization were identified
based on ICD9 code 740.0e759.9. These diagnoses were
made either clinically or by autopsy for live births that died
during birth hospitalization. In order to avoid double
counting, we restricted our inclusion criteria to birth de-
fects made during birth hospitalization. We ensured this by
including only hospitalizations with ICD-9 code for normal
and complicated delivery (650.0e669.0), thereby excluding
diagnoses made during interhospital transfer or readmission
hospitalization.
2.2. Disease and racial classification
In patients with multiple birth defects, each malformation
was counted separately. We grouped all birth defects into
different organ-systems. Based on the classification system
used by Christensen et al,19 we defined multi organ-system
involvement as live births with birth defects involving two
or more organ-systems. For racial classification, we adop-
ted the classification system used in the NIS database which
coded all birth entries into five ethnic/racial categories:
Caucasians (nonHispanic whites), AfricaneAmericans
(Blacks), Hispanics, Asians, and Native Americans based on
the ethnicity of the mother.18,20 In cases where a mother’s
racial data were not available, NIS coded such birth entries
as unknown. As per HCUP data use agreement prohibiting
reporting of cell size 10, birth defect diagnoses with one
cell size 10 were excluded from subanalysis. For the
purpose of our study, we excluded Native Americans from
our analysis because almost all birth defect diagnoses in the
racial group had insufficient cell size (cell size 10).
2.3. Statistical analysis
Data weighting were performed with SAS (SAS Institute Inc.,
100 SAS Campus Drive, Cary, NC 27513-2414, USA) in
accordance with HCUP Recommendations (http://www.
hcupus.ahrq.gov/reports/methods/1998ChangesintheNIS
RedesignFinal.pdf). We estimated birth prevalence of birth
defect diagnoses among Caucasians. We then used MedCalc
for Windows, version 12.5 (MedCalc Software, Ostend,
Belgium) to estimate the relative risk (RR) and 95% confi-
dence interval (CI) for 55 selected birth defect diagnoses in
AfricaneAmericans, Hispanics, and Asians relative to
Caucasians.
3. Results
There were 1,204,887 live birth hospitalizations in the 2008
NIS dataset and out of this population we included
1,048,252 live births (87 %) with available race data. Our
cohort comprised 534,608 (51%) Caucasians, 178,292 (17%)
AfricaneAmericans, 220,182 (21%) Hispanics, and 47,427
(4.5%) Asians. The racial distribution in our cohort was
consistent with the national racial distribution as reported
in the 2008 United States (US) report census.21,22 Birth
prevalence of birth defects was 29.2 per 1000 live births in
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1000 among Caucasians (nZ 15,932), 27.8 per 1000 among
AfricaneAmericans (n Z 4967), 28.3 per 1000 among His-
panics (n Z 6245), and 30.1 per 1000 among Asians
(n Z 1426). Compared with Caucasians, the risk of birth
defect was lower in AfricaneAmericans (RR Z 0.9, CI
0.8e0.9) and Hispanics (RR Z 0.9, CI 0.8e0.9). The risk of
birth defects was similar in Caucasians and Asians (Table 1).
Relative to the Caucasians, AfricaneAmericans had a
lower risk of cardiac malformations (RR 0.9; CI 0.8e0.9);
genitourinary malformations (RR 0.7; CI 0.7e0.8); cranio-
facial malformations (RR 0.4; CI 0.3e0.6); and a higher risk
of musculoskeletal malformations (RR 1.2; CI 1.1e1.4).
Hispanics had a lower risk of genitourinary malformation
(RR 0.8; CI 0.7e0.8) and gastrointestinal malformation (RR
0.8; CI 0.7e0.9). Asians had a higher risk of craniofacial
malformation (RR 1.7; CI 1.3e2.2), and musculoskeletal
malformation (RR 1.2; CI 1.1e1.4) (Tables 2 and 3).
With regards to lesion-specific risk, six birth defect di-
agnoses (ventricular septal defect, lower urinary tract
obstruction, hypospadias, neural tube defect, cleft lip, and
cleft lip-palate) were less prevalent in AfricaneAmericans
whereas two birth defect diagnoses (congenital hip dislo-
cation and congenital foot anomaly) were more prevalent
in AfricaneAmericans compared with Caucasians. Two birth
defect diagnoses (hypospadias and upper gastrointestinal
anomaly) were less prevalent in Hispanics whereas three
birth defect diagnoses (atrial septal defect, renal dysplasia,
and omphalocele/gastroschisis) were more prevalent in
Hispanics. Asians had a higher risk of lower urinary tract
anomaly, Hirschsprung disease, and congenital hip dislo-
cation, but a lower risk of ventricular septal defect and
hypospadias compared with Caucasians (Tables 2 and 3).
Apart from the risk of Down syndrome, which was signifi-
cantly higher in Hispanics, our cohort did not show any
racial difference in overall and lesion-specific risk of ge-
netic syndromes (Table 4).4. Discussion
Our study presents up-to-date, population-based estimates
and comprehensive analysis of racial differences in the
birth prevalence of birth defects in the Unites States. Birth
prevalence of birth defects in our cohort was 29.2 per 1000Table 1 Racial distribution of birth defects.
CAUC AfricanAmerican
No. No. RR (CI)/p
Total BD 15,932 4967 0.9(0.80.9)/<0.001y
Multiple BD 683 191 1.0(0.81.2)/0.1
Genetic synd 795 201 0.9(0.81.1)/0.09
BD prevalence* 29.8 27.8
Live births 534,608 178,292
BDZ birth defect; CAUCZ Caucasians; CIZ confidence interval; Mult
risk; synd Z syndrome.
* Prevalence per 1000 live births.
y Statistical significance.live births with a lower risk of birth defects among Afri-
caneAmericans and Hispanics compared with Caucasians
and Asians. Differences between our data and estimates
from prior studies serve as an indirect measure of the ef-
fect of modification of prenatal risk factors such as prenatal
vitamin supplementation and termination of pregnancy for
fetal anomalies. Our data will also be of help in determining
the resources needed for basic and public health research
into major birth defects.
Apart from Carmichael and Iyasu,5 we were unable to
identify any large population-based study that performed a
comprehensive analysis of racial differences in the preva-
lence of major birth defect diagnoses in the United States.
Although such comprehensive data are lacking, data on
racial differences in the prevalence of a few specific
congenital malformations do exist. For example, in agree-
ment with our findings, several studies have shown that
Hispanics have a low risk of hypospadia but a higher risk of
atrial septal defect and renal dysplasia compared with
Caucasians.9,23e27 However, unlike prior studies, our data
did not show any differences in the risk of neural tube
defect (NTD) or hypoplastic left heart syndrome in His-
panics. In the AfricaneAmerican cohort, our data were
consistent with some prior studies that showed a lower risk
of NTD, hypospadias, cleft lip-palate, and ventricular
septal defect in this population relative to
Caucasians.8,9,24,27e29 However, unlike the above-cited
studies, our data showed an increased risk of congenital
hip dislocation in AfricaneAmericans. There is paucity of
comparative data on the risk of birth defect among Asians
in the United States. Our study showed that although the
risk of overall birth defects was similar in Caucasians and
Asians; Asian newborns had a higher risk of Hirschsprung
disease and congenital hip dislocation but a lower risk of
ventricular septal defect and hypospadias relative to Cau-
casians. Thus, our data confirm some previous findings but
in general contribute to the relatively sparse literature
about the racial differences of birth defect prevalence in
the United States.
National estimates of the prevalence of birth defects
represent an important foundation in our understanding of
the public health burden posed by these conditions.
Although some previous studies have looked at racial dif-
ferences in the occurrence of selected birth defect diag-
noses,8e10,24e29 there are certain strengths and novelty inHispanic Asian
No. RR (CI)/p No. RR (CI)/p
6245 0.9(0.80.9)/<0.001y 1426 1.0(1.01.1)/0.3
321 0.9(0.71.3)/0.09 46 1.1(0.81.4)/0.3
360 1.1(1.01.3)/0.08 57 0.8(0.61.1)/0.1
28.3 30.1
22012 47427
iple BDZ birth defect affecting 2 organ-systems; RRZ relative
Table 2 Racial differences of birth defect prevalence.
CAUCA AfricanAmerican Hispanic Asian
No. No. RR (CI) No. RR (CI) No. RR (CI)
Cardiac 6038 1452 0.9(0.80.9)* 2319 0.9(0.91.0) 482 0.9(0.81.0)
TOF/DORV 181 50 1.0(0.71.4) 72 1.0(0.81.3) 16 1.0(0.61.7)
Atrial septal defect 905 244 0.9(0.81.1) 433 1.2(1.11.3)* 84 1.1(0.91.3)
Ventricular septal defect 2266 465 0.7(0.70.8)* 844 0.9(0.81.0) 156 0.8(0.70.9)*
Tricuspid atresia 45 12 1.0(0.51.8) 19 1.1(0.61.8) y
Aortic stenosis 159 44 1.0(0.71.4) 65 1.0(0.71.3) 14 1.0(0.61.7)
CoA/IAA 176 48 1.0(0.71.4) 71 1.0(0.71.3) 15 0.9(0.61.7)
Truncus arteriosus 43 12 1.0(0.51.9) 18 1.0(0.61.8) y
HLHS 72 20 1.0(0.61.6) 29 1.0(0.71.5) y
D-TGA 169 46 1.0(0.71.4) 68 1.0(0.81.3) 15 1.0(0.61.7)
Endocardial cushion defect 131 37 1.0(0.71.5) 54 1.0(0.81.4) 12 1.0(0.61.9)
pulmonary valve disease 399 112 1.0(0.81.2) 165 1.0(0.91.2) 36 1.0(0.71.5)
APVR 39 13 1.2(0.62.3) 16 1.0(0.61.8) y
Genito-urinary 6113 1223 0.7(0.70.8)* 1948 0.8(0.70.8)* 544 1.1(0.91.6)
Polycystic kidney disease 59 11 0.7(0.41.3) 18 0.8(0.41.3) y
Cystic kidney disease NOS 60 15 0.7(0.41.3) 18 0.8(0.41.3) y
UPJ obstruction 24 y 11 1.1(0.62.3) y
Lower urinary tract obst 1323 162 0.4(0.40.5)* 526 1.0(0.91.1) 167 1.5(1.21.7)*
Renal agenesis 176 32 0.7(0.51.0) 60 0.9(0.61.1) 16 1.0(0.61.7)
Renal displasia 126 44 1.3(0.91.8) 86 1.7(1.32.2)* 12 1.1(0.62.0)
Kidney anomaly NOS 195 43 0.8(0.61.1) 82 1.1(0.81.4) 18 1.1(0.71.8)
Hypospadias 1721 329 0.7(0.60.8)* 297 0.4(0.40.5)* 100 0.7(0.50.8)*
Epispadias 467 73 0.6(0.40.7) 74 0.4(0.30.5) 52 1.3(1.01.7)
Genital anomaly NOS 240 52 0.8(0.61.1) 86 0.9(0.701.1) 19 0.9(0.61.4)
Gastrointestinal 781 249 1.2(1.01.3) 246 0.8(0.70.9)* 99 1.5(1.21.9)*
TEF/esophageal anomaly 110 20 0.6(0.41.0) 41 0.9(0.61.3) 13 1.3(0.72.4)
Intestinal atresia 147 42 1.1(0.71.5) 62 1.1(0.81.4) 18 1.4(0.92.3)
Hirschsprung’s disease 49 15 1.1(0.62.0) 14 0.8(0.51.4) 12 2.8(1.55.3)*
Upper GI anomaly NOS 289 91 1.2(0.91.5) 48 0.4(0.30.6)* 23 0.9(0.61.4)
Lower GI anomaly NOS 142 49 1.2(0.91.8) 43 0.8(0.51.1) 21 1.7(1.12.7)
Hepatobiliary disease 41 18 1.6(0.92.8) 35 1.5(0.92.5) y
APVR Z anomalous pulmonary venous return; CAUCA Z Caucasians; COA/IAA Z coarctation of aorta/interrupted aortic arch; d-
TGAZ complete transposition of great arteries; GIZ gastrointestinal; HLHSZ hypoplastic left heart syndrome; NOSZ not otherwise
specified; obst Z obstruction; TEF Z tracheoesophageal fistula; TOF/DORV Z tetralogy of fallot/double outlet right ventricle;
UPJ Z uteropelvic junction.
* Statistical significance.
y Cell size < 11.
186 A.C. Egbeour study that makes it different from any other prior
study. Firstly, our data was derived from the largest na-
tional database of hospitalization information with a sam-
ple size of 1.2 million live births, marking the largest study
of birth defect birth prevalence in the United States. Due to
our large sample size, our study was powered enough for
comprehensive analysis of racial differences in the preva-
lence of 55 different birth defect diagnoses. Secondly, our
estimates were based on weighted data collected from
w1000 hospitals in 42 states; sampled to w20% of United
States community hospitals. As a result, our study popula-
tion is representative of the general newborn population in
the country. In support of this, the racial distribution of our
cohort was strikingly similar to the racial distribution of the
national newborn population as reported in the 2008 United
States (US) Census Bureau database.21,22 Finally, most prior
studies that looked at the effect of race on birth defectprevalence only focused on a few selected diagnoses. Our
data, however, constitute a comprehensive analysis of all
major birth defects in the newborn population. Carmichael
et al30 performed a comprehensive analysis of major birth
defects among Caucasians, AfricaneAmericans, and His-
panics; but our study went a step further by including
Asians in the analysis because there is paucity of epidemi-
ologic data regarding this racial group.
Our study has some limitations. It is a retrospective re-
view of entries from a deidentified administrative data-
base. We studied birth defect prevalence among live births,
excluding all birth defect diagnoses in stillbirths and elec-
tively terminated fetuses. It has been reported that pre-
natal diagnosis of malformations is less likely among
Hispanic and AfricaneAmerican women than Caucasian
women.15,16 This situation could have led to an underesti-
mation of birth defect prevalence in Caucasians. We only
Table 3 Racial differences of birth defect prevalence.
CAUCA AfricanAmerican Hispanic Asian
No. No. RR (CI) No. RR (CI) No. RR (CI)
Neurologic 858 259 1.1(0.91.3) 239 1.1(0.91.3) 121 0.8(0.51.1)
Anencephaly 97 30 1.1(0.81.7) 41 1.0(0.71.5) 18 0.8(0.41.5)
Encephalocele 143 39 0.8(0.61.2) 44 1.2(0.91.6) 22 1.0(0.51.9)
Microcephaly 169 43 0.9(0.71.3) 36 1.0(0.81.3) 13 0.9(0.51.6)
Hydrocephalus 91 39 0.8(0.61.2) 31 1.2(0.91.6) 17 1.0(0.51.9)
Brain anomaly NOS 103 43 0.9(0.71.3) 38 1.0(0.81.3) 13 0.9(0.51.6)
Spinal bifida/NTD 109 32 0.6(0.40.9)* 26 1.2(0.91.5) 13 0.8(0.41.3)
Craniofacial 451 84 0.4(0.30.6)* 142 1.1(0.91.3) 68 1.7(1.32.2)*
Cleft lip & palate 282 46 0.4(0.30.5)* 80 1.2(0.81.3) 52 1.7(1.32.0)
Ear anomaly NOS 29 13 1.6(0.93.1) 20 1.7(0.93.0) y
Microphthalmos 44 14 1.0(0.81.3) 11 0.8(0.41.5) 13 1.5(0.71.9)
Eye anomaly NOS 55 11 1.2(0.62.3) 14 1.0(0.51.9) 11 1.8(0.62.2)
Respiratory 620 149 1.0(0.81.2) 246 1.1(0.91.3) 45 0.9(0.71.3)
Choanal atresia 41 11 1.0(0.51.9) 15 0.9(0.51.6) y
Laryngotracheal anomaly 269 67 0.9(0.71.2) 96 0.9(0.71.1) 34 1.6(0.93.1)
Cystic lung malformations 79 31 1.6(0.93.1) 11 0.9(0.41.9) y
Agenesis of lung 46 21 1.7(1.02.8) 28 1.5(0.92.4) 14 1.2(0.62.3)
Lung malformation NOS 160 45 1.0(0.71.4) 78 1.2(0.91.5) 19 1.3(0.82.2)
Musculoskeletal 974 323 1.2(1.11.4)* 446 0.7(1.01.3) 117 1.2(1.11.4)*
Congenital hip dislocation 480 167 1.2(1.11.5)* 223 1.2(1.01.4) 67 1.6(1.22.0)*
Congenital foot abnormality 355 151 1.2(1.01.5) 210 1.2(0.91.4 47 1.2(0.91.6)
Pectus 89 24 1.7(1.02.8) 23 0.8(0.41.6) 14 1.5(0.92.4)
Others 407 100 0.9(0.71.1) 205 1.3(1.11.5) 28 0.8(0.51.2)
Omph/Gastroschisis 305 82 1.0(0.81.3) 157 1.3(1.115)* 15 0.6(0.31.0)
Diaphragmatic hernia 102 18 0.6(0.41.1) 48 1.2(0.81.7) 13 1.5(0.82.6)
CAUCA Z Caucasians; NOS Z not otherwise specified; NTD Z Neural tube defect; Omph Z Omphalocele.
* Statistical significance.
y Cell size < 11.
Birth defects in the newborn population 187included birth defect diagnosis made during birth hospi-
talization, and as a result we could not have missed cases
that presented after birth hospitalization. Newborn data in
the NIS database was not linked to maternal data, and so
we were unable to control for confounding factors such as
maternal age and exposure to other prenatal risk factors.
Finally, the NIS database had some missing race/ethnicityTable 4 Racial differences of genetic syndrome prevalence.
Genetic syndromes CAUCA AfricanAmerican
No. No. RR (CI)
Down 533 155 1.1(0.91.3)
Patau 25 11 1.6(0.83.3)
Edward 24 12 1.8(0.93.7)
Turner 23 11 1.6(0.83.5)
Klinefelter 15 y
Noonan 25 12 1.6(0.83.3)
All genetic syndromes 795 201 0.9(0.81.1)
CAUCA Z Caucasians.
* Statistical significance.
y Cell size < 11.data and this factor has to be taken into consideration
when interpreting our results.
5. Conclusion
Despite the limitations, our data represent a comprehen-
sive description of the risks of birth defects amongHispanic Asian
No. RR (CI) No. RR (CI)






360 1.1(1.01.3) 57 0.8(0.61.1)
188 A.C. Egbenewborns in the different racial groups and constitute an
important descriptive resource for comparison with other
studies. Race-ethnicity may serve as a surrogate for a va-
riety of potential exposures (e.g., socioeconomic level,
nutrition, stress, access to medical care, and migration
decisions). It remains to be clarified whether the observed
racial differences in risk of birth defects are related to
potential underlying genetic susceptibilities, difference in
maternal age in the different races, difference in prenatal
exposure to teratogens, or to combinations of these
factors.
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